42 results
8-K
EX-99.1
TRVN
Trevena Inc
14 Nov 23
Trevena Reports Third Quarter 2023 Results and Provides Business Update
12:00am
and tolerability data from TRV045 POC studies
Three abstracts for OLINVYK presented at American Society of Anesthesiologists (ASA) Conference
$15 million
8-K
EX-99.2
TRVN
Trevena Inc
2 Oct 23
Regulation FD Disclosure
7:05am
at American Society of Anesthesiologists Conference
Continuous respiratory monitoring data for ~200 complex surgical patients treated with IV … to be presented at the American Society of Anesthesiologists Meeting October 13-17, 2023
Company will also participate in the BIO Investor Forum October 17
8-K
TRVN
Trevena Inc
2 Oct 23
Regulation FD Disclosure
7:05am
of the OLINVYK continuous respiratory monitoring data from the VOLITION study and presentation of the data at the American Society
8-K
EX-99.4
joe5k1vi3kby6do
6 Sep 23
Regulation FD Disclosure
7:02am
8-K
EX-99.2
ob5m2
9 Nov 22
Trevena Reports Third Quarter 2022 Results and Provides Business Update
7:05am
8-K
EX-99.1
7gg8zer
9 Nov 22
Trevena Reports Third Quarter 2022 Results and Provides Business Update
7:05am
8-K
EX-99.2
6eemk 054t
28 Jul 22
Trevena Announces Positive Topline OLINVYK Cognitive Function Data and Provides General Business Update
7:06am
8-K
EX-99.1
9mypg0
20 Apr 22
Regulation FD Disclosure
5:11pm
8-K
EX-99.2
eusx6eowdyvm
31 Mar 22
Trevena Reports Fourth Quarter and Full Year 2021 Results
7:04am
8-K
EX-99.1
rjkd5q35t
16 Jun 21
Regulation FD Disclosure
4:08pm
8-K
EX-99.2
jk9v2vs0fc
6 May 21
Trevena Reports First Quarter 2021 Results
7:05am
8-K
EX-99.2
mtp48z4rf6anx2c
9 Mar 21
Trevena, Inc. Reports Fourth Quarter and Full Year 2020 Results
7:02am
8-K
EX-99.1
4qs9c9m0edcqu6lybw
2 Nov 20
Regulation FD Disclosure
9:22am